Greenwich Lifesciences Inc (GLSI) — Financial Flexibility Index
Greenwich Lifesciences Inc (GLSI) has a Financial Flexibility Index of -0.90x as of March 2026. Free cash flow of $-4.70 Million (operating CF $-4.70 Million minus capex $3.00) represents -1% of total liabilities ($5.24 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Greenwich Lifesciences Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Greenwich Lifesciences Inc across 9 annual periods. See Greenwich Lifesciences Inc (GLSI) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Greenwich Lifesciences Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Greenwich Lifesciences Inc. For the full company profile including market capitalisation, see Greenwich Lifesciences Inc (GLSI) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.92x | $-9.91 Million | $-9.91 Million | $2.02 Million | ▼ -5.5% |
| 2024 | -4.66x | $-7.27 Million | $-7.27 Million | $1.56 Million | ▲ +78.8% |
| 2023 | -22.01x | $-6.48 Million | $-6.48 Million | $294.41K | ▲ +6.7% |
| 2022 | -23.58x | $-6.20 Million | $-6.20 Million | $262.90K | ▼ -111.7% |
| 2021 | -11.14x | $-4.29 Million | $-4.29 Million | $385.17K | ▼ -910.3% |
| 2020 | -1.10x | $-1.15 Million | $-1.15 Million | $1.05 Million | ▼ -417.8% |
| 2019 | -0.21x | $-293.27K | $-293.27K | $1.38 Million | ▼ -1795.0% |
| 2018 | -0.01x | $-114.95K | $-114.95K | $10.23 Million | ▲ +20.4% |
| 2017 | -0.01x | $-120.85K | $-120.85K | $8.56 Million | — |